Cost-Effectiveness of Lay Responder Defibrillation for Out-of-Hospital Cardiac Arrest

Annals of Emergency Medicine

Volumn 54, Issue 2, 2009, Pages

  Nichol, Graham ^a   Huszti, Ella ^b   Birnbaum, Alice ^c   Mahoney, Brian ^d   Weisfeldt, Myron ^e   Travers, Andrew ^f   Christenson, Jim ^g   Kuntz, Karen ^h  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c Axio Research Corporation   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f DALHOUSIE UNIVERSITY   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; SURVIVAL RATE; TREATMENT OUTCOME; VOLUNTEER;

CANADA; CARDIOPULMONARY RESUSCITATION; COST-BENEFIT ANALYSIS; DEFIBRILLATORS; ELECTRIC COUNTERSHOCK; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; VOLUNTARY WORKERS;

EID: 67650395603     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2009.01.021     Document Type: Article

References (49)

1. National Center for Health Statistics. Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1990 (1992), National Center for Health Statistics, Hyattsville, MD DHHS Publication No. 92-1774
2. Nichol G., Stiell I.G., Laupacis A., et al. A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med 34 (1999) 517-525
3. Hallstrom A.P., Ornato J.P., Weisfeldt M., et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 351 (2004) 637-646
4. Nichol G., Wells G.A., Kuntz K., et al. Methodological design for economic evaluation in Public Access Defibrillation (PAD) trial. Am Heart J 150 (2005) 202-208
5. Gold M.R., Siegel J.E., Russell L.B., et al. Appendix A: summary recommendations. In: Gold M.R., Siegel J.E., Russell L.B., et al. (Eds). Cost-effectiveness in Health and Medicine (1996), Oxford University Press, New York, NY 425
6. Feeny D., Furlong W., Torrance G.W., et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 40 (2002) 113-128
7. Drummond M.F., O'Brien B.J., Stoddart G.L., et al. Collection and Analysis of Data. Methods for the Economic Evaluation of Health Care Programs. 2d ed. (1997), Oxford University Press, Oxford, England 232-264
8. Stinnett A.A., and Paltiel A.D. Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means. Med Decis Making 17 (1997) 483-489
9. Creasey M.A. Limits for the ratio of means. J R Stat Soc B 16 (1954) 186-194
10. Naimark D., Krahn M.D., Naglie G., et al. Primer on medical decision analysis: part 5-working with Markov processes. Med Decis Making 17 (1997) 152-159
11. TreeAge Software Inc. Decision Analysis by TreeAge. DATA for Windows. Version 4.0. User's Manual (2001), TreeAge Software Inc, Boston, MA
12. Drummond M.F., Sculpher M.J., Torrance G.W., et al. Methods for the Economic Evaluation of Health Care Programs. 3rd ed. (2005), Oxford University Press, Oxford, England
13. Russell L.B., Siegel J.E., Daniels N., et al. Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Gold M.R., Siegel J.E., Russell L.B., et al. (Eds). Cost-effectiveness in Health and Medicine (1996), Oxford University Press, New York, NY 3-24
14. Bardy G.H., Lee K.L., Mark D.B., et al. Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med 358 (2008) 1793-1804
15. Fenwick E., Marshall D.A., Levy A.R., et al. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res 6 (2006) 52
16. Briggs A., Sculpher M., and Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 3 (1994) 95-104
17. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman and Hall, New York, NY
18. de Wit G.A., Ramsteijn P.G., and de Charro F.T. Economic evaluation of end stage renal disease treatment. Health Policy 44 (1998) 215-232
19. CDC Diabetes Cost-Effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287 (2002) 2542-2551
20. Graham J.D., Thompson K.M., Goldie S.J., et al. The cost-effectiveness of air bags by seating position. JAMA 278 (1997) 1418-1425
21. Boomsma D., Busjahn A., and Peltonen L. Classical twin studies and beyond. Nat Rev Genet 3 (2002) 872-882
22. Valenzuela T.D., Roe D.J., Nichol G., et al. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med 343 (2000) 1206-1209
23. Katz K.A., Bernstein K.T., and Klausner J.D. Does ascertainment bias affect reports on the incidence of multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus infection?. Ann Intern Med 149 (2008) 65 author reply 66
24. Sayre M.R., Travers A.H., Daya M., et al. Measuring survival rates from sudden cardiac arrest: the elusive definition. Resuscitation 62 (2004) 25-34
25. Roine R.O., Kajaste S., and Kaste M. Neuropsychological sequelae of cardiac arrest. JAMA 269 (1993) 237-242
26. Becker L., Eisenberg M., Fahrenbruch C., et al. Public locations of cardiac arrest. Implications for public access defibrillation. Circulation 97 (1998) 2106-2109
27. Kaplan R.M., and Bush J.W. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology 1 (1982) 61-80
28. Laupacis A., Feeny D., Detsky A.S., et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 146 (1992) 473-481
29. King Jr. J.T., Tsevat J., Lave J.R., et al. Willingness to pay for a quality-adjusted life-year: implications for societal health care resource allocation. Med Decis Making 25 (2005) 667-677
30. McClellan M.B., and Tunis S.R. Medicare coverage of ICDs. N Engl J Med 352 (2005) 222-224
31. Garber A.M., and Phelps C.E. Economic foundations of cost-effectiveness analysis. J Health Econ 16 (1997) 1-31
32. Nichol G., Powell J., van Ottingham L., et al. Consent in resuscitation trials: benefit or harm for patients and society?. Resuscitation 70 (2006) 360-368
33. Nichol G., Hallstrom A., Ornato J.P., et al. Potential cost-effectiveness of public access defibrillation in the United States. Circulation 97 (1998) 1315-1320
34. Nichol G., Laupacis A., Stiell I., et al. A cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med 27 (1996) 711-720
35. Groeneveld P.W., Kwong J.L., Liu Y., et al. Cost-effectiveness of automated external defibrillators on airlines. JAMA 286 (2001) 1482-1489
36. Caffrey S.L., Willoughby P.J., Pepe P.E., et al. Public use of automated external defibrillators. N Engl J Med 347 (2002) 1242-1247
37. Nichol G., Valenzuela T., Roe D., et al. Cost-effectiveness of defibrillation by targeted responders in public settings. Circulation 108 (2003) 697-703
38. Walker A., Sirel J.M., Marsden A.K., et al. Cost-effectiveness and cost utility model of public place defibrillators in improving survival after prehospital cardiopulmonary arrest. BMJ 327 (2003) 1316-1320
39. Boyle M., Furlong W., Torrance G., et al. Reliability of the Health Utilities Index-Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire. Qual Life Res 4 (1995) 249-257
40. Feeny D., Furlong W., Boyle W., et al. Multi-attribute health status classification systems: Health Utilities Index. PharmacoEconomics 7 (1995) 490-502
41. Nichol G., Stiell I.G., Hebert P., et al. What is the quality of life of survivors of cardiac arrest? a prospective study. Acad Emerg Med 6 (1999) 95-102
42. Bergner L., Bergner M., Hallstrom A.P., et al. Service factors and health status of survivors of out-of-hospital cardiac arrest. Am J Emerg Med 1 (1983) 259-263
43. Nichol G., Thomas E., Callaway C.W., et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 300 (2008) 1423-1431
44. Lerner E.B., Nichol G., Spaite D.W., et al. A comprehensive framework for determining the cost of an emergency medical services system. Ann Emerg Med 49 (2007) 304-313
45. Mohr P.E., Cheng C.M., and Mueller C.D. Establishing a fair Medicare reimbursement for low-volume rural ambulance providers. Policy Anal Brief W Ser 4 (2001) 1-4
46. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 33 (1997) 1576-1583
47. Larsen G., Hallstrom A., McAnulty J., et al. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation 105 (2002) 2049-2057
48. Luce B.R., Manning W.G., Siegel J.E., et al. Estimating costs in cost-effectiveness analysis. In: Gold M.R., Siegel J.E., Russell L.B., et al. (Eds). Cost-effectiveness in Health and Medicine (1996), Oxford University Press, New York, NY 176-213
49. Connolly S.J., Hallstrom A.P., Cappato R., et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 21 (2000) 2071-2078